BE860614A - Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments - Google Patents

Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments

Info

Publication number
BE860614A
BE860614A BE182455A BE182455A BE860614A BE 860614 A BE860614 A BE 860614A BE 182455 A BE182455 A BE 182455A BE 182455 A BE182455 A BE 182455A BE 860614 A BE860614 A BE 860614A
Authority
BE
Belgium
Prior art keywords
preparation process
medicinal products
alkylated hydroxylamines
hydroxylamines
alkylated
Prior art date
Application number
BE182455A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BE860614A publication Critical patent/BE860614A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BE182455A 1976-11-09 1977-11-08 Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments BE860614A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762651083 DE2651083A1 (de) 1976-11-09 1976-11-09 Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
BE860614A true BE860614A (fr) 1978-05-08

Family

ID=5992722

Family Applications (1)

Application Number Title Priority Date Filing Date
BE182455A BE860614A (fr) 1976-11-09 1977-11-08 Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments

Country Status (18)

Country Link
US (1) US4404384A (xx)
JP (1) JPS5817454B2 (xx)
AT (1) AT363452B (xx)
AU (1) AU520996B2 (xx)
BE (1) BE860614A (xx)
CA (1) CA1081242A (xx)
CH (1) CH641757A5 (xx)
DE (1) DE2651083A1 (xx)
DK (1) DK496977A (xx)
ES (1) ES463803A1 (xx)
FI (1) FI773353A (xx)
FR (1) FR2370028A1 (xx)
GB (1) GB1540028A (xx)
HU (1) HU176533B (xx)
IL (1) IL53337A0 (xx)
NL (1) NL188157C (xx)
SE (1) SE441265B (xx)
ZA (1) ZA776670B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
US4965390A (en) * 1990-02-02 1990-10-23 Ciba-Geigy Corporation Hydroxamic acid esters
US5075504A (en) * 1990-02-02 1991-12-24 Ciba-Geigy Corporation Process for the preparation of O-substituted hydroxylamines
IL97759A0 (en) * 1990-04-11 1992-06-21 Ciba Geigy Ag Hydroxylamine compounds
HU207290B (en) * 1990-06-13 1993-03-29 Sandoz Ag Process for producing hydroxamic acid derivatives and pharmaceutical compositions containing them
EP0495750A3 (en) * 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine
DE4244390A1 (de) * 1992-12-29 1994-06-30 Basf Ag Verfahren zur Herstellung von Oximino-Derivaten und neue Oximino-Derivate
HU218480B (hu) * 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
NZ533795A (en) 2002-01-11 2006-03-31 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE102005044108A1 (de) 2005-09-15 2007-03-29 Bayer Cropscience Ag Dioxazin- und Oxdiazin-substituierte Arylamide
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
WO2013113915A1 (en) * 2012-02-03 2013-08-08 Novartis Ag Process for preparing n-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester
EP4247792A1 (en) 2020-11-19 2023-09-27 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149364B (de) * 1960-07-05 1963-05-30 Bayer Ag Verfahren zur Herstellung von O-(Alkylamino)-hydroxylaminen
GB1017601A (en) * 1961-02-22 1966-01-19 Lepetit Spa O-(ª‰-hydroxyethyl)-hydroxylamine and derivatives thereof
US3262978A (en) * 1963-06-19 1966-07-26 Colgate Palmolive Co O-arylamino-and-aralkyl-amino-alkylhydroxyl-amines
US3342678A (en) * 1964-02-10 1967-09-19 Carter Wallace Lowering blood cholesterol levels in warm-blooded animals with phenoxyethoxy or phenoxy-propoxy amine derivatives
HU162578B (xx) * 1971-02-15 1973-03-28
SE397088B (sv) * 1972-06-17 1977-10-17 Sumitomo Chemical Co Forfarande for framstellning av nya 2-propanolderivat
DE2651084A1 (de) * 1976-11-09 1978-12-14 Hoechst Ag Basisch substituirte o-(2-hydroxypropyl) -aldoxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
DE2658762A1 (de) * 1976-12-24 1978-06-29 Hoechst Ag Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2820013A1 (de) * 1978-05-08 1979-11-22 Hoechst Ag Verfahren zur herstellung von o-alkylierten hydroxylaminen

Also Published As

Publication number Publication date
FI773353A (fi) 1978-05-10
SE441265B (sv) 1985-09-23
NL188157B (nl) 1991-11-18
JPS5817454B2 (ja) 1983-04-07
HU176533B (en) 1981-03-28
ES463803A1 (es) 1978-06-16
AU3043377A (en) 1979-05-17
NL7712291A (nl) 1978-05-11
NL188157C (nl) 1992-04-16
DE2651083C2 (xx) 1988-08-04
IL53337A0 (en) 1978-01-31
CA1081242A (en) 1980-07-08
SE7712630L (sv) 1978-05-10
FR2370028B1 (xx) 1980-06-20
US4404384A (en) 1983-09-13
ZA776670B (en) 1978-08-30
AU520996B2 (en) 1982-03-11
CH641757A5 (en) 1984-03-15
GB1540028A (en) 1979-02-07
DK496977A (da) 1978-05-10
JPS5368711A (en) 1978-06-19
FR2370028A1 (fr) 1978-06-02
AT363452B (de) 1981-08-10
DE2651083A1 (de) 1978-05-18
ATA794477A (de) 1981-01-15

Similar Documents

Publication Publication Date Title
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
FR2352791A1 (fr) P. acylaminobenzamides, procede pour leur preparation et medicaments contenant ces benzamides
BE864834A (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
BE860614A (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
BE865015A (fr) Pseudotrisaccharides, leur procede de preparation et medicament les contenant
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
BE854072A (fr) Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament
FR2308361A1 (fr) Nouvelles 3,4-dihydrospiro-2h-1,3-benzoxazines utiles comme medicaments
PT65456B (fr) Procede de preparation de dihyro-1,4 pyridines utilisablesnotamment comme medicaments antihypertenseurs et antiangoreux
BE862302A (fr) Nouvelles oximes 0-alkylees, leur procede de preparation et leur emploi comme medicaments
FR2346354A1 (fr) Nouvelles as-triazinobenzodiazepine-1-ones, leur procede de preparation et medicament les contenant
BE862303A (fr) Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
FR2344285A1 (fr) Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
FR2320740A1 (fr) Derives du thiaxanthene, utilisables comme medicaments neuroleptiques et leur procede de preparation
BE861137A (fr) Ortho-aminoacetophenones utiles comme medicaments et procede pour leur preparation
BE866588A (fr) Derives de 2-benzyl-perhydroazepines, procede pour leur preparation et application comme medicaments
BE860615A (fr) 0-(hydroxy-2 propyl) aldoximes substitues basiquement, leur procede de preparation et leur emploi comme medicaments
LU78914A1 (fr) Nouvelles arylenedioxy-bis-dicetones,leur preparation et leur utilisation comme medicaments
BE861337A (fr) Nouveaux derives imidazoliques leur procede de preparation et leur application comme medicaments
FR2302733A1 (fr) Nouvelles arylalcoylamines substituees, procede pour leur preparation et leur utilisation comme medicaments
FR2348924A1 (fr) Nouvelles carbonylpiperazinylquinazolines azoliques,leur procede de preparation et medicament les contenant
FR2346352A1 (fr) Nouvelles triazinobenzodiazepines, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HOECHST A.G.

Effective date: 19951130